Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.230
+0.150 (4.87%)
At close: Sep 4, 2026, 4:00 PM EDT
3.200
-0.030 (-0.93%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $496.06 million as of September 4, 2026. Its market cap has increased by 120.67% in one year.
Market Cap
496.06M
Enterprise Value
299.93M
1-Year Change
120.67%
Ranking
Category
Stock Price
$3.23
ChartMarket Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $620.67M to $496.06M, a decrease of -20.08%. That is a compound annual growth rate of -2.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 496.06M | 147.89% |
| Dec 31, 2025 | 200.12M | 90.89% |
| Dec 31, 2024 | 104.84M | -87.33% |
| Dec 29, 2023 | 827.35M | 38.68% |
| Dec 30, 2022 | 596.59M | -66.78% |
| Dec 31, 2021 | 1.80B | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 492.83M |
| Eupraxia Pharmaceuticals | 490.48M |
| Puma Biotechnology | 485.74M |
| Rezolute | 474.28M |
| Ginkgo Bioworks Holdings | 468.01M |
| Atea Pharmaceuticals | 466.79M |
| Relmada Therapeutics | 466.15M |
| C4 Therapeutics | 460.11M |